ConductScience.org, home

Paper39669195

Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis.

Huang K and 5 others. Front Pharmacol, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis. Papers, record 39669195. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39669195

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis.
PubMed
Journal
Front Pharmacol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.62, provisional
iCite
Revised in PubMed
2024-12-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang KKaiyue
2Lv MMi
3Zheng TTing
4Wang FFengyun
5Tang XXudong
6Lv LLin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124559811Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial.Complement Ther Med2014https://conductscience.org/library/papers/24559811PubMed
221437019Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths?Gastroenterol Hepatol (N Y)2010https://conductscience.org/library/papers/21437019PubMed
325161692Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: a pilot, randomized controlled study.Evid Based Complement Alternat Med2014https://conductscience.org/library/papers/25161692PubMed
426558923Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome.Expert Opin Pharmacother2015https://conductscience.org/library/papers/26558923PubMed
532623701Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial.Chin J Integr Med2020https://conductscience.org/library/papers/32623701PubMed
632961342Potential Benefit With Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol2021https://conductscience.org/library/papers/32961342PubMed
727487786Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.Chin J Integr Med2018https://conductscience.org/library/papers/27487786PubMed
827308645Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome.J Gastrointestin Liver Dis2016https://conductscience.org/library/papers/27308645PubMed
931463606Placebos and the Placebo Effect in Drug Trials.Handb Exp Pharmacol2019https://conductscience.org/library/papers/31463606PubMed
1014984373Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.Aliment Pharmacol Ther2004https://conductscience.org/library/papers/14984373PubMed
1135943515Placebo: a brief updated review.Naunyn Schmiedebergs Arch Pharmacol2022https://conductscience.org/library/papers/35943515PubMed
1222008217The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.BMJ2011https://conductscience.org/library/papers/22008217PubMed
1329856472Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.Aliment Pharmacol Ther2018https://conductscience.org/library/papers/29856472PubMed
1434304784Epidemiology and Burden of Irritable Bowel Syndrome: An International Perspective.Gastroenterol Clin North Am2021https://conductscience.org/library/papers/34304784PubMed
1512138321A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula.Digestion2002https://conductscience.org/library/papers/12138321PubMed
1633192627Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders.Front Psychiatry2020https://conductscience.org/library/papers/33192627PubMed
177119132An investigation of drug expectancy as a function of capsule color and size and preparation form.J Clin Psychopharmacol1982https://conductscience.org/library/papers/7119132PubMed
1824660584Curative effect of warming kidney and fortifying spleen recipe on diarrhea-predominant irritable bowel syndrome.J Tradit Chin Med2013https://conductscience.org/library/papers/24660584PubMed
1935483627Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial.Complement Ther Med2022https://conductscience.org/library/papers/35483627PubMed
2026133902Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.Clin Gastroenterol Hepatol2015https://conductscience.org/library/papers/26133902PubMed

See all 44 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42688762Pathogenesis and therapeutic strategies for irritable bowel syndrome: an integrated perspective from dynamic balance theory of Chinese medicine.Front Med (Lausanne)2026https://conductscience.org/library/papers/42688762PubMed
42614517Multidimensional evaluation of four chaihu-shugan-san simulated decoction for use as placebo controls: a comparative study.Front Pharmacol2026https://conductscience.org/library/papers/42614517PubMed
42065756Pathophysiology-driven use of natural products in irritable bowel syndrome: a review.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42065756PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39669195

GET https://conductscience.org/api/papers/v1/39669195/references?page=2